ClinicalTrials.govpublic full text
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
diagnostic self evaluation, central nervous system diseases, cns, contrast agent, mri, dotarem, magnevist, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 857164
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.